Treating NSCLC with tyrosine kinase / EGFR inhibitors erlotinib & gefitinib (Review)
Treating NSCLC with tyrosine kinase / EGFR inhibitors erlotinib & gefitinib: Cataldo VD, NEJM 2011;364:947-955. Non small cell lung cancer chemotherapy treatment review.